HGF can bind to MET, which is a transmembrane receptor of the tyrosine kinase superfamily, and its inhibitory effects on tissue fibrosis have been confirmed in various research models, such as residual kidney, unilateral ureteral obstruction, and diabetic nephropathy. Here, MET is linked to diabetic kidney disease.